UNSPSC 85522705: Revision of autologous tissue substitute in upper vein, external approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in upper vein, external approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 05WYX7Z

UNSPSC 85522705 Revision of autologous tissue substitute in upper vein, external approach is a Commodity code that shows little relevant recent state and local procurement activity. The recent opportunities tagged under this code span occupational medical surveillance, pharmacy benefit management, specialty surgical networks, independent medical evaluations for pension disability determinations, emergency and specialty care for detained youth, and temporary health professional staffing — none of which align with the code's nominal scope of tissue-substitute revision procedures. The mismatch suggests either systematic miscoding by issuing bodies or a fundamental disconnect between the UNSPSC taxonomy entry and actual state and local buying patterns in this domain.

The opportunities sourced across Arizona, California, Washington, and Texas issuing bodies — the City of Phoenix Retirement Office (RFP for independent medical evaluation services, due October 16, 2026), the City of Long Beach (RFP for surgical benefit carve-out programs, due October 7, 2026), the Washington State Department of Transportation on behalf of Washington State Ferries (RFP for occupational medical surveillance, due October 9, 2026), Harris County Juvenile Probation Department (RFI for emergency and specialty medical services, due September 25, 2026), Collier County Board of County Commissioners (RFP for pharmacy benefit management, due April 9, 2026 — a past-due deadline suggesting this record is stale), and Santa Clara County Health System (RFQ for temporary health professional staffing, due October 7, 2026) — indicate activity across state departments, counties, and special healthcare systems, but none procure autologous tissue substitutes or revision procedures. Unless bidders are interpreting this code as a catch-all for healthcare service management broadly, the code merits close attention before resource allocation; confirm with issuing bodies whether the tagging reflects actual procurement intent or represents a cataloging error.